Open access
Sep 2026
Beyond seropositivity: SARS-CoV-2 IgG responses in high-risk COVID-19 patients.
Findings highlight variant-specific limitations of anti-Spike IgG as a universal marker of protection and support the need for integrated serological and virological assessment to guide antiviral and monoclonal antibody strategies in vulnerable populations.
Matteo Domenico Marsiglia, Roberta Rovito, A. Amendola et al.
· Journal of microbiology, imm... · 0 citations